Efficacy of Botulinum toxin type A in treatment of different forms of focal dystonias in the Serbian population: Experience of the Botulinum Toxin Outpatients Department

Efficacy of Botulinum toxin type A in treatment of different forms of focal dystonias in the Serbian population: Experience of the Botulinum Toxin Outpatients Department

Background/Aim. Botulinum toxin (BTX) irreversibly inhibits presynaptic acetylcholine release with subsequent relaxation of abnormally contracting muscles. It is an effective and well tolerated treatment with long-term benefit in a variety of movement disorders and other neurological and...

Full description

Bibliographic Details
Main Authors: Tomić Aleksandra, Vujović Balša, Svetel Marina, Dragašević-Mišković Nataša, Petrović Igor, Pekmezović Tatjana, Kostić Vladimir S.
Format: Article
Language:English
Published: Military Health Department, Ministry of Defance, Serbia 2015-01-01
Series:Vojnosanitetski Pregled
Subjects:
dystonia
botulinum toxins
Serbia
questionnaires
quality of life
Online Access:http://www.doiserbia.nb.rs/img/doi/0042-8450/2015/0042-84501500114T.pdf

Internet

http://www.doiserbia.nb.rs/img/doi/0042-8450/2015/0042-84501500114T.pdf

Similar Items